Van Cutsem E, Sagaert X, Topal B, et al. Gastric cancer[J]. Lancet. 2016;388(10060):2654–64.
Article
Google Scholar
Crew KD, Neugut AI. Epidemiology of gastric cancer[J]. World J Gastroenterol WJG. 2006;12(3):354.
Article
Google Scholar
Sitarz R, Skierucha M, Mielko J, et al. Gastric cancer: epidemiology, prevention, classification, and treatment[J]. Cancer Manag Res. 2018;10:239.
Article
CAS
Google Scholar
Dai F, Wu Y, Lu Y, et al. Crosstalk between RNA m6A modification and non-coding RNA contributes to cancer growth and progression[J]. Mol Ther Nucl Acids. 2020;22:62.
Article
CAS
Google Scholar
Coker H, Wei G, Brockdorff N. m6A modification of non-coding RNA and the control of mammalian gene expression[J]. Biochim et Biophys Acta (BBA)-Gene Regul Mech. 2019;1862(3):310–8.
Article
CAS
Google Scholar
Lan Y, Liu B, Guo H. The role of M6A modification in the regulation of tumor related lncRNAs[J]. Mol Ther Nucl Acids. 2021;24:768.
Article
CAS
Google Scholar
Binnewies M, Roberts EW, Kersten K, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy[J]. Nat Med. 2018;24(5):541–50.
Article
CAS
Google Scholar
Keren L, Bosse M, Marquez D, et al. A structured tumor-immune microenvironment in triple negative breast cancer revealed by multiplexed ion beam imaging[J]. Cell. 2018;174(6):1373–87.
Article
CAS
Google Scholar
Taube JM, Klein A, Brahmer JR, et al. Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti–PD-1 therapy[J]. Clin Cancer Res. 2014;20(19):5064–74.
Article
CAS
Google Scholar
Chen SMY, Krinsky AL, Woolaver RA, et al. Tumor immune microenvironment in head and neck cancers[J]. Mol Carcinog. 2020;59(7):766–74.
Article
CAS
Google Scholar
Shen S, Yan J, Zhang Y, et al. N6-methyladenosine (m6A)-mediated messenger RNA signatures and the tumor immune microenvironment can predict the prognosis of hepatocellular carcinoma[J]. Ann Transl Med. 2021;9(1):59.
Article
CAS
Google Scholar
Qiu X, Yang S, Wang S, et al. M6A demethylase ALKBH5 regulates PD-L1 expression and tumor immunoenvironment in intrahepatic cholangiocarcinoma[J]. Cancer Res. 2021;81:4778.
Article
CAS
Google Scholar
Li R, Yin YH, Ji XL, et al. Pan-cancer prognostic, immunity, stemness, and anticancer drug sensitivity characterization of N6-methyladenosine RNA modification regulators in human cancers[J]. Front Mol Biosci. 2021. https://doi.org/10.3389/fmolb.2021.644620.
Article
PubMed
PubMed Central
Google Scholar
Li J, Wang W, Zhou Y, et al. m6A regulator-associated modification patterns and immune infiltration of the tumor microenvironment in hepatocarcinoma[J]. Front Cell Dev Biol. 2021;9:1679.
Google Scholar
Wang H, Meng Q, Ma B. Characterization of the prognostic m6A-related lncRNA signature in gastric cancer[J]. Front Oncol. 2021;11:927.
CAS
Google Scholar
Zheng J, Guo J, Cao B, et al. Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer[J]. Cancer Cell Int. 2021;21(1):1–18.
Article
Google Scholar
Yu H, Zhang Z. ALKBH5-mediated m6A demethylation of lncRNA RMRP plays an oncogenic role in lung adenocarcinoma[J]. Mamm Genome. 2021;32(3):195–203.
Article
CAS
Google Scholar
Li Z, Li Y, Zhong W, et al. m6A-related lncRNA to develop prognostic signature and predict the immune landscape in bladder cancer[J]. J Oncol. 2021;2021:1–16.
Google Scholar
Ji F, Lu Y, Chen S, et al. m6A methyltransferase METTL3-mediated lncRNA FOXD2-AS1 promotes the tumorigenesis of cervical cancer[J]. Mol Ther Oncolytics. 2021;22:574.
Article
CAS
Google Scholar
Wen S, Wei Y, Zen C, et al. Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine[J]. Mol Cancer. 2020;19(1):1–18.
Article
Google Scholar
Wang J, Su Z, Lu S, et al. LncRNA HOXA-AS2 and its molecular mechanisms in human cancer. Clin Chim Acta. 2018;485:229–33.
Article
CAS
Google Scholar
Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965–81.
Article
CAS
Google Scholar
He RZ, Luo DX, Mo YY. Emerging roles of lncRNAs in the post-transcriptional regulation in cancer. Genes Dis. 2019;6(1):6–15.
Article
CAS
Google Scholar
Cui N, et al. Long non-coding RNA LINC00511 regulates the expression of microRNA-625-5p and activates signal transducers and activators of transcription 3 (STAT3) to accelerate the progression of gastric cancer. Bioengineered. 2021;12(1):2915–27.
Article
CAS
Google Scholar
Wang H, et al. Long non-coding RNA LINC00649 regulates YES-associated protein 1 (YAP1)/Hippo pathway to accelerate gastric cancer (GC) progression via sequestering miR-16-5p. Bioengineered. 2021;12(1):1791–802.
Article
CAS
Google Scholar
Lv Z, et al. Joint analysis of lncRNA m(6)A methylome and lncRNA/mRNA expression profiles in gastric cancer. Cancer Cell Int. 2020;20:464.
Article
CAS
Google Scholar
Wang XJ, et al. LINC00106 prevents against metastasis of thyroid cancer by inhibiting epithelial-mesenchymal transition. Eur Rev Med Pharmacol Sci. 2020;24(19):10015–21.
PubMed
Google Scholar
Wu Y, et al. A risk score model with five long non-coding RNAs for predicting prognosis in gastric cancer: an integrated analysis combining TCGA and GEO datasets. PeerJ. 2021;9: e10556.
Article
Google Scholar
Qi M, et al. Integrated analysis of a ceRNA network reveals potential prognostic lncRNAs in gastric cancer. Cancer Med. 2020;9(5):1798–817.
Article
CAS
Google Scholar
Gu Y, et al. TYMSOS drives the proliferation, migration, and invasion of gastric cancer cells by regulating ZNF703 via sponging miR-4739. Cell Biol Int. 2021;45(8):1710–9.
Article
CAS
Google Scholar
Xu S, Tang L, Dai G, et al. Expression of m6A regulators correlated with immune microenvironment predicts therapeutic efficacy and prognosis in gliomas[J]. Front Cell Dev Biol. 2020;8:1335.
Google Scholar
Du J, Ji H, Ma S, et al. m6A regulator-mediated methylation modification patterns and characteristics of immunity and stemness in low-grade glioma[J]. Brief Bioinf. 2021. https://doi.org/10.1093/bib/bbab013.
Article
Google Scholar
Fang J, Hu M, Sun Y, et al. Expression profile analysis of m6A RNA methylation regulators indicates they are immune signature associated and can predict survival in kidney renal cell carcinoma[J]. DNA Cell Biol. 2020;39(12):2194–211.
Article
CAS
Google Scholar
Wu XR, Chen Z, Liu Y, et al. Prognostic signature and immune efficacy of m1A-, m5C-and m6A-related regulators in cutaneous melanoma[J]. J Cell Mol Med. 2021;25:8405.
Article
CAS
Google Scholar
Chong W, Shang L, Liu J, et al. m6A regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer[J]. Theranostics. 2021;11(5):2201.
Article
CAS
Google Scholar
Bai R, et al. Pan-cancer analyses demonstrate that ANKRD6 is associated with a poor prognosis and correlates with M2 macrophage infiltration in colon cancer. Chin J Cancer Res. 2021;33(1):93–102.
Article
CAS
Google Scholar
Zhang Z, Wang Z, Huang Y. Comprehensive analyses of the infiltrating immune cell landscape and its clinical significance in hepatocellular carcinoma. Int J Gen Med. 2021;14:4695–704.
Article
Google Scholar
Ma YY, et al. Interaction of coagulation factors and tumor-associated macrophages mediates migration and invasion of gastric cancer. Cancer Sci. 2011;102(2):336–42.
Article
CAS
Google Scholar